Several studies have documented an increase in children being prescribed psychotropic medications. Current research shows nearly 6% of children between the ages 12 and 19 reported psychotropic drug use within the last year. Research has also shown that pharmacological treatments are effective at reducing problematic symptoms associated with several disorders. For example, methylphenidate and fluoxetine are effective at reducing problematic symptoms associated with attention-deficit-hyperactivity-disorder (ADHD) and pediatric depression respectively. However, school personnel members receive very little training in child psychopharmacology and this presents several problems in their ability to advocate evidence-based pharmacological interventions and effectively monitor student progress. The current review seeks to explore school personnel training in child psychopharmacology to highlight the need for training in evidence-based pharmacological interventions particularly in minority and low socioeconomic settings.
|Keywords:||Child Psychopharmacology, School Personnel, Teacher Training|
PhD Student, Sociology, Wayne State University, Lansing, MI, USA